Histogen Inc (HSTO): It wasn't an FDA approval. They just...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	13
Posts	385
Boards Moderated	0
Alias Born	03/17/2014

Blakechaos

Re: Jimmy99er post# 15

Thursday, 03/18/2021 5:00:54 AM

Thursday, March 18, 2021 5:00:54 AM

It wasn't an FDA approval. They just took a hold off the trial. It is still good news but they just missed a sales estimate which people don't take lightly. I still loaded more yesterday at 1.37 though, lol.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent HSTO News

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering • GlobeNewswire Inc. • 04/18/2024 09:29:15 PM
Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/04/2024 06:21:25 PM
Histogen Announces Second Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 12/14/2023 09:15:00 PM
Histogen Announces Adjournment of Special Meeting of Stockholders • GlobeNewswire Inc. • 12/05/2023 09:05:00 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 11/16/2023 09:07:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/18/2023 08:05:05 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/04/2023 08:08:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:05:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 08:06:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:16:54 PM
Histogen Announces Board Approval of Complete Liquidation and Dissolution • GlobeNewswire Inc. • 09/18/2023 08:05:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 08:05:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:26:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 09:18:51 PM
Histogen to Explore Strategic Alternatives • GlobeNewswire Inc. • 07/05/2023 08:05:00 PM
Histogen Reports First Quarter 2023 Results and Provides Business Update • GlobeNewswire Inc. • 05/11/2023 08:05:00 PM

More HSTO News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover